Preclinical drug development for childhood cancer

被引:7
作者
Moreno, Lucas [1 ,2 ]
Chesler, Louis [1 ,2 ]
Hargrave, Darren [1 ]
Eccles, Suzanne A. [3 ]
Pearson, Andrew D. J. [1 ,4 ]
机构
[1] Royal Marsden NHS Fdn Trust, Children & Young Peoples Unit, Sutton SM2 5PT, Surrey, England
[2] Inst Canc Res, Sect Paediat Oncol, Neuroblastoma Drug Dev Team, Surrey, England
[3] Canc Res UK Ctr Canc Therapeut, Inst Canc Res, Surrey, England
[4] Inst Canc Res, Sect Paediat Oncol, Surrey, England
关键词
animal models; cancer; cell lines; children; drug development; targeted therapy; ENGINEERED MOUSE MODELS; BRAIN-STEM GLIOMA; HEDGEHOG PATHWAY INHIBITOR; PHASE-I TRIALS; N-MYC; MALIGNANT PROGRESSION; TESTING PROGRAM; IGF-1; RECEPTOR; MEDULLOBLASTOMA; CHILDREN;
D O I
10.1517/17460441.2011.537652
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Importance of the field: More effective drugs are needed to treat poor prognosis paediatric malignancies. Development of anticancer agents for childhood cancers faces several unique challenges compared with their adult counterparts. Areas covered in this review: We demonstrate how recent advances in preclinical drug development may overcome these difficulties and challenges. We explain the role of academia, regulators and industry in this field, address issues with preclinical models and illustrate several examples of biology-driven drug development in childhood cancers. What the reader will gain: Increased knowledge about preclinical drug development in paediatric oncology including different preclinical models, established preclinical research networks, and relationships among academia, industry and regulators, as illustrated by several examples of targeted agents in childhood solid malignancies. Take home message: It is anticipated that emerging advanced preclinical models and testing platforms will provide a more efficient, biologically-driven rationale to support the use of targeted therapies in several malignancies such as neuroblastoma, medulloblastoma or high grade glioma which account for the majority of deaths related to childhood cancer.
引用
收藏
页码:49 / 64
页数:16
相关论文
共 50 条
[41]   Ex Vivo Drug Screening: An Emerging Paradigm in the Treatment of Childhood Cancer [J].
Ahmed, Anees ;
Cox, Ellen ;
Lane, Louis ;
Rominiyi, Ola ;
Danson, Sarah ;
Bryant, Helen E. ;
Wells, Greg ;
King, David .
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2025, 47 (05) :e144-e154
[42]   Measuring fear of cancer recurrence in survivors of childhood cancer: Development and preliminary validation of the Fear of Cancer Recurrence Inventory (FCRI)-Child and Parent versions [J].
Tutelman, Perri R. ;
Chambers, Christine T. ;
Heathcote, Lauren C. ;
Fernandez, Conrad V. ;
Flanders, Annette ;
Patton, Michaela ;
Schulte, Fiona S. M. ;
Guilcher, Gregory M. T. ;
Simard, Sebastien ;
MacLeod, Julia ;
Stern, Maya .
PSYCHO-ONCOLOGY, 2022, 31 (06) :911-919
[43]   Harnessing the predictive power of preclinical models for oncology drug development [J].
Honkala, Alexander ;
Malhotra, Sanjay, V ;
Kummar, Shivaani ;
Junttila, Melissa R. .
NATURE REVIEWS DRUG DISCOVERY, 2022, 21 (02) :99-114
[44]   Stem Cell Based Preclinical Drug Development and Toxicity Prediction [J].
Kumar, Dhruv ;
Baligar, Prakash ;
Srivastav, Rajpal ;
Narad, Priyanka ;
Raj, Sibi ;
Tandon, Chanderdeep ;
Tandon, Simran .
CURRENT PHARMACEUTICAL DESIGN, 2021, 27 (19) :2237-2251
[45]   Spirituality in childhood cancer care [J].
Rolim Lima, Nadia Nara ;
do Nascimento, Vania Barbosa ;
Figueiredo de Carvalho, Sionara Melo ;
Rolim Neto, Modesto Leite ;
Moreira, Marcial Moreno ;
Brasil, Aline Quental ;
Celestino Junior, Francisco Telesforo ;
de Oliveira, Gislene Farias ;
Advincula Reis, Alberto Olavo .
NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2013, 9 :1539-1544
[46]   Recent advances in childhood cancer [J].
Jurgens, H .
EUROPEAN JOURNAL OF CANCER, 1997, 33 :S15-S22
[47]   Childhood Cancer and the Risk of ESKD [J].
Calderon-Margalit, Ronit ;
Pleniceanu, Oren ;
Tzur, Dorit ;
Stern-Zimmer, Michal ;
Afek, Arnon ;
Erlich, Tomer ;
Verhovsky, Guy ;
Keinan-Boker, Lital ;
Skorecki, Karl ;
Twig, Gilad ;
Vivante, Asaf .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (02) :495-501
[48]   High-Throughput Doppler Toolbox for Preclinical Drug Development [J].
Azer, Karim ;
Desiderio, Michael C. ;
Tong, Christopher ;
Bunzel, Michelle ;
Campbell, Barry R. ;
Shevell, Diane ;
Walker, Matthew, III .
JALA, 2010, 15 (04) :287-296
[49]   A reexamination of a childhood cancer stereotype [J].
Wiens, BA ;
Gilbert, BO .
JOURNAL OF PEDIATRIC PSYCHOLOGY, 2000, 25 (03) :151-159
[50]   Ex Vivo Metrics™, a preclinical tool in new drug development [J].
C Gerald Curtis ;
Kevin Bilyard ;
Hugo Stephenson .
Journal of Translational Medicine, 6